Tuesday, July 18, 2023 1:58:48 PM
The only problem they will face now that the majority of shares are held by a devout long shareholder base is shifting real shares from Retail to Institutions when NWBO finally makes it's moves. How high a price will long term shareholders accept when the realization hits the market that a new paradigm has entered the fray and biologics become the future of medicine with of course Dendritic Cells being the core of this revolution.
We will continue to hear of low ball pricing from those employed by MM's/Hedge Funds to try and shift the enormous future profits of such a company into the hands of an already extremely wealthy elite. It will be imperative that all longtime shareholders recognize the truly lifechanging wealth that their families can gain from being such early participants in such an incredible scientific breakthrough.
Dendritic style vaccines will conquer innumerable diseases that plague mankind in an incredibly friendly way and it is up to us current shareholders to hold our ground and stay invested in what will become known as the biggest scientific breakthrough in human medicine. We owe it not only to ourselves but all our family and friends to make sure that the wealth generated by this breakthrough is not stolen by an already obscenely wealthy elite.
If the retail base holds it's ground we will see an incredible SP rise when Institutions start banging at the door for those shares. Many games will be played to try and steal your shares and it is close to the time where we as shareholders need to recognize the true value and not be duped into accepting anything less than what our families deserve.
Some current board members have been kind to post their views on what SP values should be after approval but they are not even close if Dendritic Cell's become the master of future human medicine. Some early selling is inevitable for many but make sure it is at a fair price and not a gamed price. Sell the fewest shares possible because there will never be a better investment once Dendritic Cells become the recognized king of immunotherapy.
All IMHO of course. Stay strong all.
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM